Dare Bioscience, Inc. Common Stock (DARE) is a publicly traded Healthcare sector company. As of September 11, 2026, DARE trades at $0.70 with a market cap of $14.09M and a P/E ratio of -1.00. DARE moved -0.16% today. Year to date, DARE is -63.84%; over the trailing twelve months it is -66.90%. Its 52-week range spans $0.69 to $9.19. Analyst consensus is buy with an average price target of $10.00. Rallies surfaces DARE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest DARE news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $0.70 |
| Market Cap | $14.09M |
| P/E Ratio | -1.00 |
| EPS | $-0.71 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.19 |
| 52-Week Low | $0.69 |
| Volume | 24 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.37M |
| Net Income | $-10.99M |
| Gross Margin | 0.00% |
2 analysts cover DARE: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.00.